Despite strides in expanding access to insecticide-treated nets and medicines that help prevent malaria in children and pregnant women, more people were infected with malaria in 2022, according to a new report published by the World Health Organization (WHO).
In 2022, there were an estimated 249 million malaria cases globally, exceeding 2019 by 16 million patients.
The WHO's 2023 World Malaria Report, published on November 30, 2023, discloses the changes that influence the behavior and survival of the malaria-carrying Anopheles mosquito.
Malaria Overwhelmed 11 Countries in 2022
Polio Vaccine Misinformation Goes Global
While the end of polio is within reach, immunization efforts can easily be derailed by spreading vaccine misinformation, wrote the Global Polio Eradication Initiative (GPEI).
While it is near impossible to eliminate vaccine misinformation after it has spread, national health systems can actively monitor for and address misinformation as it arises. Digital Community Engagement enables countries to bridge the gap between their on-the-ground work and digital communities while fostering trust in childhood immunization.
U.S. Government Wants Additional RSV Passive Immunization Supply
The U.S. Administration recently confirmed officials met with suppliers to discuss the manufacturing, distribution, and accessibility of Respiratory Syncytia Virus (RSV) immunizations through the private market.
On November 27, 2023, senior administration officials underscored the importance of manufacturers such as Sanofi and AstraZeneca working to meet demand with a sense of urgency.
CDC: 2021 to 2022 Saw Increase in U.S. Life Expectancy
Increase in life expectancy seen for males and females and for American Indian and Alaska Native, Hispanic, Black, Asian, White populations
Prevalence of COVID-19 Variant BA.2.86 Rising in the United States
Preliminary data on the variant suggest it does not trigger more severe illness than previous variants
Fourth COVID-19 Shot Beneficial in Patients With Autoimmune Rheumatic Diseases
Fourth dose reduces risk for SARS-CoV-2 for patients with systemic autoimmune rheumatic diseases using DMARDs
Fluvoxamine Does Not Shorten Duration of COVID-19 Symptoms
Findings observed among adults with mild or moderate COVID-19
Microarray Skin Patch Successfully Delivers Measles Vaccines
The journal Vaccines recently reported that microarray patches (MAPs) have the potential to be a safer, more acceptable, easier-to-use, and more cost-effective means for the administration of vaccines than injection by needle and syringe.
COVID-19 Vaccination Before Infection Cuts Risk for Long COVID
COVID-19 vaccination with any number of doses before infection linked to reduced risk for post-COVID-19 condition
Mpox Outbreaks Continue in Late 2023
The World Health Organization (WHO) today reported that the multi-country mpox outbreak continues at a low transmission level in the European Region and the Americas.
The 30th WHO Situation Report, published on November 25, 2023, offers insights regarding the latest epidemiology and a particular focus on the ongoing and evolving epidemiology of mpox in the Democratic Republic of the Congo (DRC).